Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population

Ja. Hubacek, O. Viklicky, D. Dlouha, S. Bloudickova, R. Kubinova, A. Peasey, H. Pikhart, V. Adamkova, I. Brabcova, E. Pokorna, M. Bobak

. 2012 ; 27 (3) : 1030-1035.

Language English Country England, Great Britain

Document type Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc12034923

BACKGROUND: Genome-wide association studies identified the FTO (fat mass and obesity gene) gene as an important determinant of body weight. More recently, the FTO gene was reported to be associated with other outcomes, including major risk factors for chronic kidney disease (CKD). We investigated the role of this gene in the risk of end-stage renal disease (ESRD) caused by CKD. METHODS: We conducted two large population-based case-control studies of ESRD. Study 1 compared 984 haemodialysed patients with ESRD with 2501 participants in the Czech post-MONICA study; Study 2 compared 1188 patients included in a kidney transplantation programme for ESRD with 6681 participants in the Czech HAPIEE study. The frequencies of the FTO rs17817449 single nucleotide polymorphism genotype were compared between cases and controls. RESULTS: The FTO rs17817449 genotype was significantly associated with CKD in both studies (P-values 0.00004 and 0.006, respectively). In the pooled data, the odds ratios of CKD for GG and GT, versus TT genotype, were 1.37 (95% confidence interval 1.20-1.56) and 1.17 (1.05-1.31), respectively (P for trend <0.0001). Among haemodialysed and kidney transplant patients, the onset of ESRD in GG homozygotes was 3.3 (P = 0.012) and 2.5 (P = 0.032) years, respectively, earlier than in TT homozygotes. CONCLUSIONS: These two large independent case-control studies in the general population found robust associations between the FTO rs17817449 polymorphism and the ESRD. The results suggest that the morbidities associated with the FTO gene include CKD.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12034923
003      
CZ-PrNML
005      
20200505133652.0
007      
ta
008      
121023s2012 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ndt/gfr418 $2 doi
035    __
$a (PubMed)21788373
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hubáček, Jaroslav, $d 1966- $7 nlk20050169367 $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Centre for Cardiovascular Research, Prague, Czech Republic
245    14
$a The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population / $c Ja. Hubacek, O. Viklicky, D. Dlouha, S. Bloudickova, R. Kubinova, A. Peasey, H. Pikhart, V. Adamkova, I. Brabcova, E. Pokorna, M. Bobak
520    9_
$a BACKGROUND: Genome-wide association studies identified the FTO (fat mass and obesity gene) gene as an important determinant of body weight. More recently, the FTO gene was reported to be associated with other outcomes, including major risk factors for chronic kidney disease (CKD). We investigated the role of this gene in the risk of end-stage renal disease (ESRD) caused by CKD. METHODS: We conducted two large population-based case-control studies of ESRD. Study 1 compared 984 haemodialysed patients with ESRD with 2501 participants in the Czech post-MONICA study; Study 2 compared 1188 patients included in a kidney transplantation programme for ESRD with 6681 participants in the Czech HAPIEE study. The frequencies of the FTO rs17817449 single nucleotide polymorphism genotype were compared between cases and controls. RESULTS: The FTO rs17817449 genotype was significantly associated with CKD in both studies (P-values 0.00004 and 0.006, respectively). In the pooled data, the odds ratios of CKD for GG and GT, versus TT genotype, were 1.37 (95% confidence interval 1.20-1.56) and 1.17 (1.05-1.31), respectively (P for trend <0.0001). Among haemodialysed and kidney transplant patients, the onset of ESRD in GG homozygotes was 3.3 (P = 0.012) and 2.5 (P = 0.032) years, respectively, earlier than in TT homozygotes. CONCLUSIONS: These two large independent case-control studies in the general population found robust associations between the FTO rs17817449 polymorphism and the ESRD. The results suggest that the morbidities associated with the FTO gene include CKD.
650    _2
$a dospělí $7 D000328
650    _2
$a věk při počátku nemoci $7 D017668
650    _2
$a senioři $7 D000368
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a DNA $x genetika $7 D004247
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a celogenomová asociační studie $7 D055106
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a chronické selhání ledvin $x epidemiologie $x genetika $7 D007676
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a polymerázová řetězová reakce $7 D016133
650    _2
$a polymorfismus genetický $x genetika $7 D011110
650    _2
$a proteiny $x genetika $7 D011506
650    _2
$a rizikové faktory $7 D012307
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Viklický, Ondřej, $d 1966- $7 nlk20050170291 $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Dlouhá, Dana. $7 xx0204810 $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Centre for Cardiovascular Research, Prague, Czech Republic
700    1_
$a Bloudickova, Silvie $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kubínová, Růžena, $d 1947- $7 xx0082854 $u Environmental Health Centre, National Institute of Public Health, Prague, Czech Republic
700    1_
$a Peasey, Anne $u Department of Epidemiology and Public Health, University College London, London, UK
700    1_
$a Pikhart, Hynek $7 xx0107140 $u Department of Epidemiology and Public Health, University College London, London, UK
700    1_
$a Adámková, Věra, $d 1954- $7 jx20050329003 $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Brabcová, Irena $7 xx0079327 $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Pokorná, Eva, $d 1965- $7 xx0063976 $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Bobák, Martin, $d 1963- $7 xx0092245 $u Department of Epidemiology and Public Health, University College London, London, UK
773    0_
$w MED00010288 $t Nephrology, dialysis, transplantation official publication of the European Dialysis and Transplant Association - European Renal Association $x 1460-2385 $g Roč. 27, č. 3 (2012), s. 1030-1035
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21788373 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20121023 $b ABA008
991    __
$a 20200505133650 $b ABA008
999    __
$a ok $b bmc $g 956933 $s 792420
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 27 $c 3 $d 1030-1035 $i 1460-2385 $m Nephrology, dialysis, transplantation $n Nephrol Dial Transplant $x MED00010288
LZP    __
$b NLK112 $a Pubmed-20121023

Find record

Citation metrics

Archiving options